NeuroSense Therapeutics Ltd. Other General and Administrative Expense
NeuroSense Therapeutics Ltd. (NRSN) reported Other General and Administrative Expense of $466.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2026-03-31
| Period end | Other General and Administrative Expense 12 month |
|---|---|
| 2025-12-31 | $466.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $534.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $641.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $371.00K 20-F · filed 2025-04-07 |